| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |